These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29088896)

  • 1. Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience.
    Vetter M; Fokas S; Biskup E; Schmid T; Schwab F; Schoetzau A; Güth U; Rochlitz C; Zanetti-Dällenbach R
    Oncotarget; 2017 Sep; 8(43):75617-75626. PubMed ID: 29088896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.
    Walsh EM; Shalaby A; O'Loughlin M; Keane N; Webber MJ; Kerin MJ; Keane MM; Glynn SA; Callagy GM
    Breast Cancer Res Treat; 2019 Feb; 174(1):1-13. PubMed ID: 30488345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis.
    Pathak N; Sharma A; Elavarasi A; Sankar J; Deo SVS; Sharma DN; Mathur S; Kumar S; Prasad CP; Kumar A; Batra A
    Breast; 2022 Aug; 64():7-18. PubMed ID: 35462344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neo-adjuvant therapy for triple-negative breast cancer: Insights from a network meta-analysis.
    Miyashita H; Satoi S; Cruz C; Malamud SC
    Breast J; 2020 Sep; 26(9):1717-1728. PubMed ID: 32657479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival.
    Kern P; Kalisch A; von Minckwitz G; Pütter C; Kolberg HC; Pott D; Kurbacher C; Rezai M; Kimmig R
    J Chemother; 2016 Jun; 28(3):210-7. PubMed ID: 26239282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review.
    Tian H; Ma D; Tan X; Yan W; Wu X; He C; Zhong L; Zhang Y; Yu B; Zhang Y; Qi X
    Front Pharmacol; 2021; 12():770663. PubMed ID: 34938186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and prognostic analysis of Triple-negative Breast Cancer: Single institute experience.
    Maka VV; Pancha H; Shukla SN; Talati SS; Shah PM; Patel KM; Anand AS; Shah SA; Patel AA; Parikh S
    Gulf J Oncolog; 2016 Jan; 1(20):38-44. PubMed ID: 27050178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.
    Bouchalova K; Svoboda M; Kharaishvili G; Vrbkova J; Bouchal J; Trojanec R; Koudelakova V; Radova L; Cwiertka K; Hajduch M; Kolar Z
    Tumour Biol; 2015 Jun; 36(6):4243-52. PubMed ID: 25616695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum-based chemotherapy in triple-negative advanced breast cancer.
    Villarreal-Garza C; Khalaf D; Bouganim N; Clemons M; Peña-Curiel O; Baez-Revueltas B; Kiss A; Kassam F; Enright K; Verma S; Pritchard K; Myers J; Dent R
    Breast Cancer Res Treat; 2014 Aug; 146(3):567-72. PubMed ID: 25001611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice?
    Agrawal LS; Mayer IA
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):654-8. PubMed ID: 25658890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial.
    Wang J; Shi M; Ling R; Xia Y; Luo S; Fu X; Xiao F; Li J; Long X; Wang J; Hou Z; Chen Y; Zhou B; Xu M
    Radiother Oncol; 2011 Aug; 100(2):200-4. PubMed ID: 21852010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronomic methotrexate and cyclophosphamide after carboplatin included adjuvant chemotherapy in triple negative breast cancer: a phase III study.
    Nasr KE; Osman MA; Elkady MS; Ellithy MA
    Ann Transl Med; 2015 Nov; 3(19):284. PubMed ID: 26697444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete response.
    Kern P; Kalisch A; Kolberg HC; Kimmig R; Otterbach F; von Minckwitz G; Sikov WM; Pott D; Kurbacher C
    Chemotherapy; 2013; 59(5):387-94. PubMed ID: 24852315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment.
    Chang HR; Glaspy J; Allison MA; Kass FC; Elashoff R; Chung DU; Gornbein J
    Cancer; 2010 Sep; 116(18):4227-37. PubMed ID: 20549829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
    Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
    Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.
    Khalifa J; Duprez-Paumier R; Filleron T; Lacroix Triki M; Jouve E; Dalenc F; Massabeau C
    Breast J; 2016 Sep; 22(5):510-9. PubMed ID: 27261365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India.
    Lakshmaiah KC; Anand A; Babu KG; Dasappa L; Jacob LA; Babu M C S; Lokesh KN; Rudresha AH; Rajeev LK; Saldanha SC; Giri GV; Koppaka D
    World J Oncol; 2017 Aug; 8(4):110-116. PubMed ID: 29147445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based chemotherapy in metastatic triple negative breast cancer: Experience of a tertiary referral centre in India.
    Maka VV; Panchal H; Shukla SN; Talati SS;
    Gulf J Oncolog; 2015 Jan; 1(17):52-7. PubMed ID: 25682453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.